Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-Ligand Affinity Descriptor: (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMIN
Chronic Myeloid Leukemia (CML) is primarily treated using Imatinib mesylate, a tyrosine kinase inhibitor (TKI) targeting the Bcr-Abl oncoprotein. However, the development of drug resistance and advers
Crystal structure of E. coli penicillin-binding protein 5 in complex with a peptide-mimetic cephalosporin Descriptor: (2R)-2-[(R)-{[(6S)-6-amino-6-carboxyhexanoyl]amino}(carboxy)methyl]-5-methyl-3,6-d